US generics players Bayshore Pharmaceuticals and Unichem Pharmaceuticals USA could soon be combined into a single US generic formulations player, under plans unveiled by Bayshore owner and Unichem majority shareholder Ipca Laboratories.
Ipca and Unichem both announced via BSE filings today that a meeting of the board of directors would be held...